Boston Scientific’s Device To Relieve Severe Asthma: A Major Opportunity – Seeking Alpha

Boston Scientific's Device To Relieve Severe Asthma: A Major Opportunity
Seeking Alpha
Earlier in 2012 Boston Scientific's incoming CEO Michael Mahoney said about the Alair asthma treatment that it will be marketed in 20 countries and 200 sites by the end of the 2012. Mahoney predicted that the worldwide market for bronchial thermoplasty

View full post on asthma – Google News

Boston Scientific’s Alair Bronchial Thermoplasty System Receives Private Coverage – news Stories

Boston Scientific's Alair Bronchial Thermoplasty System Receives Private Coverage
news Stories
Minnesota-based HealthPartners and Michigan-based Priority Health recently issued the first public postings of positive insurance coverage policies providing their respective memberships with reimbursement for this procedure used to treat severe asthma
Boston Scientific Welcomes Positive Private Insurance Coverage Decisions for MarketWatch (press release)

all 11 news articles »

View full post on asthma – Google News

Boston Scientific’s Alair® Bronchial Thermoplasty System Achieves Important … – MarketWatch (press release)

Boston Scientific's Alair® Bronchial Thermoplasty System Achieves Important
MarketWatch (press release)
"It supports what we have confirmed through our clinical trials: bronchial thermoplasty offers a new advancement in the treatment of patients with severe asthma who are not well controlled despite taking recommended doses of asthma medications.

and more »

View full post on asthma – Google News

Boston Scientific’s Alair® Bronchial Thermoplasty System Achieves Important … – Sacramento Bee

Boston Scientific's Alair® Bronchial Thermoplasty System Achieves Important
Sacramento Bee
"It supports what we have confirmed through our clinical trials: bronchial thermoplasty offers a new advancement in the treatment of patients with severe asthma who are not well controlled despite taking recommended doses of asthma medications.

and more »

View full post on asthma – Google News

Clinical Data Demonstrates Long-Term Safety of Boston Scientific’s Alair[TM … – MarketWatch (press release)

Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair[TM
MarketWatch (press release)
Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European
Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair[TM Genetic Engineering News

all 6 news articles »

View full post on asthma – Google News